Cite Filings / YARW / 0001213900-24-009367
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
SC 13G/A

Amended Statement of Ownership

Yarrow Bioscience, Inc. · Filed 2024-02-02 · Acc 0001213900-24-009367

Documents 1

  • SC 13G/A Amended Statement of Ownership , ea192420-13ga1soleus_vyne.htm

Around this filing

  • 2024-02-14 SC 13G/A Amended Statement of Ownership
  • 2024-02-02 SC 13G/A Amended Statement of Ownership
  • 2022-02-15 SC 13G/A Amended Statement of Ownership

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)

Stakes reported in this filing

Stake history · largest stake in each 13D and 13G

  1. 2026-11-20 SCHEDULE 13D/A · AI Biotechnology LLC 1.16%
  2. 2026-11-17 SCHEDULE 13G/A · Logos Global Management LP 9.99%
  3. 2026-11-16 SCHEDULE 13G/A · RTW Fund Group GP, LLC 9.9%
  4. 2026-11-16 SCHEDULE 13G/A · JANUS HENDERSON GROUP Ltd. 3.0%
  5. 2026-11-16 SCHEDULE 13G/A · Perceptive Advisors LLC 9.99%
  6. 2026-11-16 SCHEDULE 13G · Ameriprise Financial, Inc. 8.6%
  7. 2026-11-16 SCHEDULE 13G/A · ADAR1 Capital Management, LLC 2.5%
  8. 2026-11-16 SCHEDULE 13G/A · venBio Global Strategic Fund V, L.P. 9.99%
  9. 2026-11-13 SCHEDULE 13G/A · Nantahala Capital Management, LLC 0.46%
  10. 2026-11-13 SCHEDULE 13G · Spruce Street Capital LP 6.4%
Loading ea192420-13ga1soleus_vyne.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…